APRIL 28, 2006 | A student in the cytotechnology program at the University of Arkansas for Medical Sciences (UAMS) became the first UAMS student to be invited to present research in that field at the national level.
Catherine Mattocks of El Dorado was among 10 students from across the country invited to present their research during the American Society for Cytotechnology meeting in April.
Mattocks presented “Exophytic villoglandular endocervical adenocarcinoma cells present in a six week post-partum pap of a twenty-seven year old woman.” Cytotechnologists learn to recognize abnormalities in cell structures as they microscopically analyze body cell samples.
Don Simpson, M.P.H., director of the cytotechnology program in the UAMS College of Health Related Professions, said Mattocks’ accomplishment demonstrates that UAMS’ program is becoming nationally recognized as one that promotes the opportunity for scholarly activity among students.
“We are proud of Catherine’s accomplishment,” Simpson said. “This also fulfills our goal of generating and communicating new knowledge in the field that results from research.”
Simpson added that Mattocks’ presentation was interesting because the type of cancer cell, villoglandular endocervical adenocarcinoma, is uncommon. Fewer than 100 cases have been reported, he said, though there is a good prognosis for the patient.
He noted that Mattocks now will have the opportunity to develop a manuscript on the work for submission to a peer-reviewed journal.
The UAMS College of Health Related Professions’ program in cytotechnology, jointly sponsored by the Department of Pathology of the UAMS College of Medicine, offers a Bachelor of Science degree in cytotechnology. Students complete three years of required course work from any regionally accredited college or university before beginning the one-year program at UAMS.
The program begins in the classroom with lectures and microscope work, progresses to proficiency in all aspects of the UAMS Department of Pathology’s Cytopathology Laboratory, and culminates with several full-time rotations through designated clinical labs.
Upon completion of the program, graduates are eligible to take the national registry examination offered by the American Society for Clinical Pathology Board of Registry and become a registered cytotechnologist.
In 2005, the U.S. Bureau of Labor Statistics projected a 17 percent increase in job demand in the next three years for cytotechnologists, which sees starting annual salaries from $41,000 to $48,000 nationally. The UAMS program is the state’s only one, and has a near 100 percent job placement and first time national board pass rate for graduates, Simpson said.
Links on This Page
UAMS Cytotechnology Program: http://www.uams.edu/chrp/cytotechnology/
American Society for Cytotechnology: http://www.asct.com/
Department of Pathology in